Drug
Prasugrel Loading Dose
Prasugrel Loading Dose: highest development phase Post-Market, developed by Daiichi Sankyo. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Daiichi Sankyo
Trials
| Drug | Phase | Indication |
|---|---|---|
| Prasugrel Loading Dose NCT01587651 | Post-Market | Coronary Artery Disease |
Latest
No recent events.
Follow Prasugrel Loading Dose on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.